Form 4: Alector Director Richard Scheller Receives RSU Grant

Director Richard Scheller acquired 10,833 restricted stock units in Alector, Inc. as part of a quarterly vesting equity grant.

Summary

• Director Richard H. Scheller was granted 10,833 restricted stock units (RSUs) of Alector, Inc. (ALEC) common stock.
• The grant was effective June 1, 2026.
• The RSUs vest in four equal quarterly installments starting on the grant date.
• Following this transaction, the director's total beneficial ownership of common stock increased to 106,199 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial strategy.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Standard equity incentive structure for board members.

Negatives

• None identified.

Risks

• General market risks associated with biotechnology equity holdings.

Future Outlook

The RSUs will vest in four equal quarterly installments, with the first installment occurring on June 1, 2026.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard practice in the biotechnology sector to ensure long-term alignment between leadership and shareholder value.

Comparison to Industry Standards

• The grant of RSUs to non-employee directors is consistent with standard corporate governance practices for NASDAQ-listed biotechnology companies.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Vesting of the remaining RSU installments on a quarterly basis.

Key Dates

Keywords

Alector, ALEC, Form 4, Insider Trading, Biotechnology, Equity Compensation